DexCom (DXCM) Financials: History & Chart

DexCom, Inc. (DXCM)DXCMDexCom, Inc.

About DexCom, Inc.

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.

San Diego, CA

11,100 employees

www.dexcom.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Jacob Steven Leach

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Revenue	4.82B	1.19B	1.26B	1.21B	1.16B	1.04B	1.11B	994.20M	1.00B
Cost of Goods Sold	1.84B	441.60M	466.90M	461.90M	468.30M	447.00M	457.70M	400.40M	377.60M
Gross Profit	2.98B	750.30M	792.70M	747.40M	688.80M	589.00M	655.80M	593.80M	626.70M
Gross Profit Margin	61.8%	62.9%	62.9%	61.8%	59.5%	56.9%	58.9%	59.7%	62.4%
Total Operating Expenses	1.95B	495.00M	469.70M	504.90M	476.20M	455.30M	466.90M	441.80M	468.70M
Research & Development	599.20M	145.30M	148.20M	157.50M	148.20M	145.20M	139.50M	135.40M	136.00M
Selling, General & Administrative	1.33B	349.70M	321.50M	331.40M	328.00M	310.10M	327.40M	306.40M	332.70M
Operating Income (EBIT)	1.03B	255.30M	323.00M	242.50M	212.60M	133.70M	188.90M	152.00M	158.00M
Operating Margin	21.4%	21.4%	25.6%	20.1%	18.4%	12.9%	17.0%	15.3%	15.7%
Income Before Tax (EBT)	1.20B	269.50M	340.70M	352.30M	241.10M	154.30M	211.30M	177.40M	187.80M
Interest Income	103.70M	19.50M	23.50M	32.70M	28.00M	28.50M	29.70M	32.00M	36.20M
Interest Expense	16.70M	3.10M	4.20M	4.70M	4.70M	4.70M	4.90M	4.70M	4.80M
Other Income/Expense	170.20M	14.20M	17.70M	109.80M	28.50M	20.60M	22.40M	25.40M	29.80M
Net Income	930.40M	199.50M	267.30M	283.80M	179.80M	105.40M	151.70M	134.60M	143.50M
Income Tax Expense	273.20M	70.00M	73.40M	68.50M	61.30M	48.90M	59.60M	42.80M	44.30M
Net Profit Margin	19.3%	16.7%	21.2%	23.5%	15.5%	10.2%	13.6%	13.5%	14.3%
EBITDA	1.29B	322.40M	388.20M	306.10M	275.60M	193.70M	246.70M	207.30M	210.10M
EBITDA Margin	26.8%	27.0%	30.8%	25.3%	23.8%	18.7%	22.2%	20.9%	20.9%
Depreciation & Amortization	258.90M	67.10M	65.20M	63.60M	63.00M	60.00M	57.80M	55.30M	52.10M
EPS Basic	2.40	0.52	0.69	0.73	0.46	0.27	0.39	0.35	0.36
EPS Diluted	2.34	0.51	0.68	0.70	0.45	0.27	0.38	0.34	0.35
Shares Outstanding	385.10M	385.10M	386.70M	391.10M	392.10M	391.10M	399.33M	394.20M	399.20M
Diluted Shares Outstanding	393.60M	393.60M	398.90M	407.40M	408.20M	407.50M	406.70M	410.20M	416.80M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	4.66B	4.03B	3.62B	2.91B	2.45B	1.93B	1.48B	1.03B
Cost of Goods Sold	1.86B	1.59B	1.33B	1.03B	768.00M	646.60M	544.50M	367.70M
Gross Profit	2.80B	2.44B	2.29B	1.88B	1.68B	1.28B	931.50M	663.90M
Gross Profit Margin	60.0%	60.5%	63.2%	64.7%	68.6%	66.4%	63.1%	64.4%
Total Operating Expenses	1.89B	1.84B	1.69B	1.49B	1.41B	980.60M	789.20M	850.20M
Research & Development	594.90M	552.40M	505.80M	484.20M	604.20M	359.90M	273.50M	417.40M
Selling, General & Administrative	1.29B	1.29B	1.19B	1.01B	810.50M	620.70M	515.70M	432.80M
Operating Income (EBIT)	911.80M	600.00M	597.70M	391.20M	265.80M	299.50M	142.30M	-186.30M
Operating Margin	19.6%	14.9%	16.5%	13.4%	10.9%	15.5%	9.6%	-18.1%
Income Before Tax (EBT)	1.09B	709.00M	710.40M	390.80M	256.80M	225.00M	104.20M	-126.50M
Interest Income	112.70M	134.20M	135.00M	23.80M	1.70M	16.10M	26.40M	2.40M
Interest Expense	18.30M	19.00M	20.30M	18.60M	18.80M	84.70M	60.30M	22.70M
Other Income/Expense	176.60M	109.00M	112.70M	-400K	-9.00M	-74.50M	-38.10M	59.80M
Net Income	836.30M	576.20M	541.50M	341.20M	216.90M	493.60M	101.10M	-127.10M
Income Tax Expense	252.10M	132.80M	168.90M	49.60M	39.90M	-268.60M	3.10M	600K
Net Profit Margin	17.9%	14.3%	14.9%	11.7%	8.9%	25.6%	6.8%	-12.3%
EBITDA	1.16B	817.70M	783.70M	547.10M	367.70M	366.60M	191.00M	-157.20M
EBITDA Margin	25.0%	20.3%	21.6%	18.8%	15.0%	19.0%	12.9%	-15.2%
Depreciation & Amortization	251.80M	217.70M	186.00M	155.90M	101.90M	67.10M	48.70M	29.10M
EPS Basic	2.14	1.46	1.44	0.88	0.56	1.31	0.28	-0.36
EPS Diluted	2.09	1.42	1.30	0.80	0.51	1.27	0.27	-0.36
Shares Outstanding	390.20M	404.63M	386.00M	389.40M	386.90M	377.60M	364.40M	352.80M
Diluted Shares Outstanding	405.50M	412.70M	425.50M	427.50M	428.80M	390.00M	369.20M	352.80M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.